Carmen C. van der Pol

Carmen C. van der Pol

Auto-generated profile, based on publicly available information

Carmen C. van der Pol

Department of Surgery, Alrijne Hospital, Leiderdorp, The Netherlands

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
JSJanine Simons
Janine Simons
LKLinetta B. Koppert
Linetta B. Koppert
ELE. J. T. Luiten
E. J. T. Luiten
CPC. C. van der Pol
C. C. van der Pol
SSS. Samiei
S. Samiei
MSMarjolein Smidt
Marjolein Smidt
Purpose: An overall trend is observed towards de-escalation of axillary surgery in patients with breast cancer. The objective of this study was to evaluate this trend in patients treated with neoadjuvant systemic therapy (NST). Methods: Patients with cT1-4N0-3 breast cancer treated with NST (2006–2016) were selected from the Netherlands Cancer Registry. Patients were classified by clinical node status (cN) and type of axillary surgery. Uni- and multivariable logistic regression analyses were performed to determine the clinicopathological factors associated with performing ALND in cN+ patients. Results: A total of 12,461 patients treated with NST were identified [5830 cN0 patients (46.8%), 6631 cN+ patients (53.2%)]. In cN0 patients, an overall increase in sentinel lymph node biopsy (SLNB) only (not followed by ALND) was seen from 11% in 2006 to 94% in 2016 (p < 0.001). SLNB performed post-NST increased from 33 to 62% (p < 0.001). In cN+ patients, an overall decrease in ALND was seen from 99% in 2006 to 53% in 2016 (p < 0.001). Age (OR 1.01, CI 1.00–1.02), year of diagnosis (OR 0.47, CI 0.44–0.50), HER2-positive disease (OR 0.62, CI 0.52–0.75), clinical tumor stage (T2 vs. T1 OR 1.32, CI 1.06–1.65, T3 vs. T1 OR 2.04, CI 1.58–2.63, T4 vs. T1 OR 6.37, CI 4.26–9.50), and clinical nodal stage (N3 vs. N1 OR 1.65, CI 1.28–2.12) were correlated with performing ALND in cN+ patients. Conclusions: ALND decreased substantially over the past decade in patients treated with NST. Assessment of long-term prognosis of patients in whom ALND is omitted after NST is urgently needed.

31 October 2014 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MBMaarten W Barentsz
Maarten W Barentsz
HWHester Wessels
Hester Wessels
PDPaul J van Diest
Paul J van Diest
RPRuud M Pijnappel
Ruud M Pijnappel
CHCees Haaring
Cees Haaring
HVHelena M Verkooijen
Helena M Verkooijen
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

7 June 2016 in JMIR Cancer
Verified
Journal Article
Open access
DYDanny A Young-Afat
Danny A Young-Afat
CGCarla H van Gils
Carla H van Gils
DBDavid J Bruinvels
David J Bruinvels
CPCarmen C van der Pol
Carmen C van der Pol
AWArjen J Witkamp
Arjen J Witkamp
HVHelena M Verkooijen
Helena M Verkooijen
Patient-Centered Innovations, Education and Technology for Cancer Care and Cancer Research

14 December 2022 in NeuroImage: Clinical
Verified
Journal Article
Open access
EKE.W. Koevoets
E.W. Koevoets
MGM.I. Geerlings
M.I. Geerlings
EME.M. Monninkhof
E.M. Monninkhof
RMR. Mandl
R. Mandl
LWL. Witlox
L. Witlox
NHNel A. van Holsteijn
Nel A. van Holsteijn
Physical exercise in cancer patients is a promising intervention to improve cognition and increase brain volume, including hippocampal volume. We investigated whether a 6-month exercise intervention primarily impacts total hippocampal volume and additionally hippocampal subfield volumes, cortical thickness and grey matter volume in previously physically inactive breast cancer patients. Furthermore, we evaluated associations with verbal memory. Chemotherapy-exposed breast cancer patients (stage I-III, 2–4 years post diagnosis) with cognitive problems were included and randomized in an exercise intervention (n = 70, age = 52.5 ± 9.0 years) or control group (n = 72, age = 53.2 ± 8.6 years). The intervention consisted of 2x1 hours/week of supervised aerobic and strength training and 2x1 hours/week Nordic or power walking. At baseline and at 6-month follow-up, volumetric brain measures were derived from 3D T1-weighted 3T magnetic resonance imaging scans, including hippocampal (subfield) volume (FreeSurfer), cortical thickness (CAT12), and grey matter volume (voxel-based morphometry CAT12). Physical fitness was measured with a cardiopulmonary exercise test. Memory functioning was measured with the Hopkins Verbal Learning Test-Revised (HVLT-R total recall) and Wordlist Learning of an online cognitive test battery, the Amsterdam Cognition Scan (ACS Wordlist Learning). An explorative analysis was conducted in highly fatigued patients (score of ≥ 39 on the symptom scale ‘fatigue’ of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire), as previous research in this dataset has shown that the intervention improved cognition only in these patients. Multiple regression analyses and voxel-based morphometry revealed no significant intervention effects on brain volume, although at baseline increased physical fitness was significantly related to larger brain volume (e.g., total hippocampal volume: R = 0.32, B = 21.7 mm3, 95 % CI = 3.0 – 40.4). Subgroup analyses showed an intervention effect in highly fatigued patients. Unexpectedly, these patients had significant reductions in hippocampal volume, compared to the control group (e.g., total hippocampal volume: B = −52.3 mm3, 95 % CI = −100.3 – −4.4)), which was related to improved memory functioning (HVLT-R total recall: B = −0.022, 95 % CI = −0.039 – −0.005; ACS Wordlist Learning: B = −0.039, 95 % CI = −0.062 – −0.015). No exercise intervention effects were found on hippocampal volume, hippocampal subfield volumes, cortical thickness or grey matter volume for the entire intervention group. Contrary to what we expected, in highly fatigued patients a reduction in hippocampal volume was found after the intervention, which was related to improved memory functioning. These results suggest that physical fitness may benefit cognition in specific groups and stress the importance of further research into the biological basis of this finding.

26 September 2016 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
CPCarmen C. van der Pol
Carmen C. van der Pol
MLMiangela M. Lacle
Miangela M. Lacle
AWArjen J. Witkamp
Arjen J. Witkamp
RKRobert Kornegoor
Robert Kornegoor
HMHui Miao
Hui Miao
PDPaul J. van Diest
Paul J. van Diest
Breast cancer in men is uncommon; it accounts for 1 % of all patients with primary breast cancer. Its treatment is mostly extrapolated from its female counterpart. Accurate predictions are essential for adjuvant systemic treatment decision-making and informing patients. Several predictive models are available for female breast cancer (FBC) including the Morphometric Prognostic Index (MPI), Nottingham Prognostic Index (NPI), Adjuvant! Online and Predict. The aim of this study was to examine and compare the prognostic performance of these models for male breast cancer (MBC).

27 June 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SPSusana Patuleia
Susana Patuleia
CMCathy Moelans
Cathy Moelans
JKJasmijn Koopman
Jasmijn Koopman
JSJulia Van Steenhoven
Julia Van Steenhoven
TDThijs van Dalen
Thijs van Dalen
Karijn SuijkerbuijkKarijn Suijkerbuijk
Karijn Suijkerbuijk
Background: Nipple fluid aspiration (NFA) is a technique to acquire nipple aspirate fluid (NAF), which is considered a rich source of breast-specific biomarkers. Originating directly from the mammary ducts, this liquid biopsy can offer insight into the process of carcinogenesis at its earliest stage and therefore could be of added value to the current imaging-based breast cancer screening tools. With that in mind, it is necessary to know how well NFA is tolerated. Aim: To evaluate the participants’ tolerability of NFA compared to breast imaging screening methods and blood draws. Materials and methods: Three cohorts of women underwent NFA: healthy women (n = 190), women diagnosed with breast cancer (n = 137) and women at high risk of developing breast cancer (n = 48). A 0–10 discomfort score of NFA, mammography, breast MRI and blood draws, was filled in at the study visits, which took place once or annually. Results: The median discomfort rate of NFA was 1, which was significantly lower than the median discomfort of mammography and breast MRI (5 and 3, respectively, p < 0.001), but significantly higher than median discomfort for blood draws (0, p < 0.001). The great majority of women would undergo the procedure again (98%) and recommend it to others (97%). Conclusion: This study shows that NFA was well tolerated by healthy women, women diagnosed with breast cancer and high-risk women. This makes NFA a feasible method to pursue as a potential future breast cancer early detection tool, based on resident biomarkers. Trial registration: NL41845.041.12, NL57343.041.16 and NL11690.041.06 in trialregister.nl.